Recce Pharmaceuticals Ltd (ASX:RCE)
Australia
· Delayed Price · Currency is AUD 0.2900
0.00 (0.00%)
Apr 30, 2025, 4:10 PM AEST
Recce Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Net Income | -17.94 | -17.66 | -13.08 | -10.99 | -13.51 | -4.32 | Upgrade
|
| Depreciation & Amortization | 0.26 | 0.37 | 0.22 | 0.19 | 0.3 | 0.2 | Upgrade
|
| Stock-Based Compensation | 0.02 | 0.02 | 0.33 | 0.26 | 5.22 | 0.06 | Upgrade
|
| Other Operating Activities | -0.03 | - | - | - | - | - | Upgrade
|
| Change in Accounts Receivable | 0.06 | 0.06 | 0.09 | 0.06 | -0.2 | -0 | Upgrade
|
| Change in Accounts Payable | 3.81 | 3.81 | 0.77 | 0.11 | 0.28 | 0.18 | Upgrade
|
| Change in Other Net Operating Assets | 0.39 | 0.39 | -1.01 | 1.36 | 0.07 | 0.08 | Upgrade
|
| Operating Cash Flow | -13.42 | -13.01 | -12.69 | -9.01 | -7.86 | -3.81 | Upgrade
|
| Capital Expenditures | -0.05 | -0.14 | -0.04 | -0.04 | -0.08 | -0.01 | Upgrade
|
| Investing Cash Flow | -0.41 | -0.14 | -0.04 | -0.04 | -0.08 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | 10.09 | 2.88 | - | - | 0.61 | Upgrade
|
| Total Debt Issued | 9.29 | 10.09 | 2.88 | - | - | 0.61 | Upgrade
|
| Short-Term Debt Repaid | - | -4.2 | - | - | - | -1.35 | Upgrade
|
| Long-Term Debt Repaid | - | -0.3 | -0.17 | -0.14 | -0.17 | -0.15 | Upgrade
|
| Total Debt Repaid | -9.33 | -4.51 | -0.17 | -0.14 | -0.17 | -1.5 | Upgrade
|
| Net Debt Issued (Repaid) | -0.05 | 5.58 | 2.71 | -0.14 | -0.17 | -0.89 | Upgrade
|
| Issuance of Common Stock | 12.53 | 11.15 | 0.1 | 0.29 | 28.06 | 6.98 | Upgrade
|
| Other Financing Activities | -0.72 | -0.73 | -0.1 | -0.39 | -1.76 | - | Upgrade
|
| Financing Cash Flow | 11.76 | 16 | 2.71 | -0.24 | 26.12 | 6.09 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | -2.06 | 2.85 | -10.02 | -9.29 | 18.19 | 2.28 | Upgrade
|
| Free Cash Flow | -13.47 | -13.15 | -12.73 | -9.05 | -7.93 | -3.81 | Upgrade
|
| Free Cash Flow Margin | -140.40% | -261.53% | -291.53% | -293.38% | -484.42% | -339.96% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.07 | -0.07 | -0.05 | -0.05 | -0.03 | Upgrade
|
| Cash Interest Paid | 0.05 | - | - | - | - | 0.06 | Upgrade
|
| Cash Income Tax Paid | - | -4.91 | -4.31 | -3.08 | -1.57 | -1.28 | Upgrade
|
| Levered Free Cash Flow | -9.06 | -7.74 | -8.16 | -4.52 | -3.1 | -2.2 | Upgrade
|
| Unlevered Free Cash Flow | -8.25 | -7.21 | -8.05 | -4.51 | -3.09 | -2.17 | Upgrade
|
| Change in Net Working Capital | -1.67 | -3.17 | 0.5 | -1.11 | 0.09 | -0.26 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.